Company research memos

55 hand-built midcap memos. Filter by verdict, industry, or company. Short news desk notes live under News.

1 memo of 55

HIKAL · Specialty Chemicals

Hikal: crop protection and pharma CDMO at an earnings trough

FY26 PAT loss near ₹49 cr despite ₹302 cr CFO; at ₹218 base FY27E implies ~55% downside, Avoid.

25 min · Yesterday